Science Alone Won’t Stop Lassa Fever

Three promising Lassa fever vaccine candidates are in clinical development, with one potentially being licensed in the next decade. To ensure a swift and effective rollout, West African countries must begin planning for vaccine distribution, including determining who should receive it, how to deliver it, and how to finance and regulate it.